273 related articles for article (PubMed ID: 24675015)
1. Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.
Das B; Kaur G; Basu S
Transfus Apher Sci; 2014 Jun; 50(3):438-42. PubMed ID: 24675015
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
Varga M; Görög D; Kári D; Környei E; Kis É; Túryné HJ; Jankovics I; Péter A; Toronyi É; Sárváry E; Fazakas J; Reusz G
Transplant Proc; 2011 May; 43(4):1233-5. PubMed ID: 21620098
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
[TBL] [Abstract][Full Text] [Related]
5. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of anti-CMV antibodies in blood donors in Ouagadougou (Burkina Faso)].
Ouédraogo AS; Yaméogo JT; Poda GE; Kientega Y; Ouédraogo Traore R
Med Sante Trop; 2012; 22(1):107-9. PubMed ID: 22871792
[TBL] [Abstract][Full Text] [Related]
7. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME).
Thiele T; Krüger W; Zimmermann K; Ittermann T; Wessel A; Steinmetz I; Dölken G; Greinacher A
Transfusion; 2011 Dec; 51(12):2620-6. PubMed ID: 21645009
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.
Furui Y; Satake M; Hoshi Y; Uchida S; Suzuki K; Tadokoro K
Transfusion; 2013 Oct; 53(10):2190-7. PubMed ID: 23968359
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
[TBL] [Abstract][Full Text] [Related]
10. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and serum profile of cytomegalovirus infection among patients with hematologic disorders in Bahia State, Brazil.
de Matos SB; Meyer R; Lima FW
J Med Virol; 2011 Feb; 83(2):298-304. PubMed ID: 21181926
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil.
Souza MA; Passos AM; Treitinger A; Spada C
Rev Soc Bras Med Trop; 2010; 43(4):359-61. PubMed ID: 20802930
[TBL] [Abstract][Full Text] [Related]
13. Is seroprevalence of anti-IGM CMV among blood donors relevant in India?
Kumar H; Gupta PK; Kumar S; Sarkar RS
Indian J Pathol Microbiol; 2008; 51(3):351-2. PubMed ID: 18723956
[TBL] [Abstract][Full Text] [Related]
14. [Antibodies to cytomegaloviruses in blood donors].
Courault K; Lissé I; Richter H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):183-6. PubMed ID: 2475395
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)].
Gargouri J; Elleuch H; Karray H; Rekik H; Hammami A
Tunis Med; 2000; 78(8-9):512-7. PubMed ID: 11190729
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.
Voruz S; Gowland P; Eyer C; Widmer N; Abonnenc M; Prudent M; Masouridi-Levrat S; Duchosal MA; Niederhauser C
Blood Transfus; 2020 Nov; 18(6):446-453. PubMed ID: 32203012
[TBL] [Abstract][Full Text] [Related]
17. Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran.
Sepehrvand N; Khameneh ZR; Eslamloo HR
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):363-7. PubMed ID: 20228534
[TBL] [Abstract][Full Text] [Related]
18. The natural course of primary cytomegalovirus infection in blood donors.
Ziemann M; Unmack A; Steppat D; Juhl D; Görg S; Hennig H
Vox Sang; 2010 Jul; 99(1):24-33. PubMed ID: 20074081
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study.
Erfanianahmadpoor M; Nasiri R; Vakili R; Hassannia T
Saudi Med J; 2014 Apr; 35(4):360-4. PubMed ID: 24749132
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
